FNY Partners Fund’s Repros Therapeutics Inc. RPRX Stock Holding History

FNY Partners Fund’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,794	Closed	-$1K	–	599
2017 Q4	$1K	Buy	+2,794	New	+$1.41K	﹤0.01%	411

FNY Partners Fund's RPRX Position: Q1 2018 in Review

FNY Partners Fund sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 2,794 shares — an estimated $1K sold.

FNY Partners Fund first reported a position in RPRX in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

FNY Partners Fund reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
FNY Partners Fund sold 2,794 Repros Therapeutics Inc. shares in Q1 2018, an estimated $1K.
FNY Partners Fund first reported a position in Repros Therapeutics Inc. in Q4 2017 and held it in 1 quarter.
FNY Partners Fund's Repros Therapeutics Inc. position peaked at $1K in Q4 2017.
1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.